Susan E Maloney1,2, Krystal C Chandler1,2, Corina Anastasaki3, Michael A Rieger1,2, David H Gutmann3, Joseph D Dougherty1. 1. Department of Genetics, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri. 2. Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri. 3. Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri.
Abstract
Neurofibromatosis type 1 (NF1) is a monogenic neurodevelopmental disease caused by germline loss-of-function mutations in the NF1 tumor suppressor gene. Cognitive impairments are observed in approximately 80% of children with this disease, with 45-60% exhibiting autism spectrum disorder (ASD) symptomatology. In light of the high comorbidity rate between ASD and NF1, we assessed early communicative behavior by maternal-separation induced pup ultrasonic vocalizations (USV) and developmental milestones in two distinct Nf1 genetically engineered models, one modeling clinical germline heterozygous loss of Nf1 function (Nf1+/- mice), and a second with somatic biallelic Nf1 inactivation in neuroglial progenitor cells (Nf1GFAP CKO mice). We observed altered USV production in both models: Nf1+/- mice exhibited both increased USVs across development and alterations in aspects of pitch, while Nf1GFAP CKO mice demonstrated a decrease in USVs. Developmental milestones, such as weight, pinnae detachment, and eye opening, were not disrupted in either model, indicating the USV deficits were not due to gross developmental delay, and likely reflected more specific alterations in USV circuitry. In this respect, increased whole-brain serotonin was observed in Nf1+/- mice, but whole-brain levels of dopamine and its metabolites were unchanged at the age of peak USV disruption, and USV alterations did not correlate with overall level of neurofibromin loss. The early communicative phenotypes reported herein should motivate further studies into the risks mediated by haploinsufficiency and biallelic deletion of Nf1 across a full battery of ASD-relevant behavioral phenotypes, and a targeted analysis of underlying circuitry disruptions. Autism Res 2018, 11: 44-58.
Neurofibromatosis type 1 (NF1) is a monogenic neurodevelopmental disease caused by germline loss-of-function mutations in the NF1tumor suppressor gene. Cognitive impairments are observed in approximately 80% of children with this disease, with 45-60% exhibiting autism spectrum disorder (ASD) symptomatology. In light of the high comorbidity rate between ASD and NF1, we assessed early communicative behavior by maternal-separation induced pup ultrasonic vocalizations (USV) and developmental milestones in two distinct Nf1 genetically engineered models, one modeling clinical germline heterozygous loss of Nf1 function (Nf1+/- mice), and a second with somatic biallelic Nf1 inactivation in neuroglial progenitor cells (Nf1GFAP CKO mice). We observed altered USV production in both models: Nf1+/- mice exhibited both increased USVs across development and alterations in aspects of pitch, while Nf1GFAP CKO mice demonstrated a decrease in USVs. Developmental milestones, such as weight, pinnae detachment, and eye opening, were not disrupted in either model, indicating the USV deficits were not due to gross developmental delay, and likely reflected more specific alterations in USV circuitry. In this respect, increased whole-brain serotonin was observed in Nf1+/- mice, but whole-brain levels of dopamine and its metabolites were unchanged at the age of peak USV disruption, and USV alterations did not correlate with overall level of neurofibromin loss. The early communicative phenotypes reported herein should motivate further studies into the risks mediated by haploinsufficiency and biallelic deletion of Nf1 across a full battery of ASD-relevant behavioral phenotypes, and a targeted analysis of underlying circuitry disruptions. Autism Res 2018, 11: 44-58.
Authors: Karin S Walsh; Jorge I Vélez; Peter G Kardel; Daniel M Imas; Maximilian Muenke; Roger J Packer; Francisco X Castellanos; Maria T Acosta Journal: Dev Med Child Neurol Date: 2012-11-16 Impact factor: 5.449
Authors: Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson Journal: Pediatrics Date: 2013-11-04 Impact factor: 7.124
Authors: C I Brannan; A S Perkins; K S Vogel; N Ratner; M L Nordlund; S W Reid; A M Buchberg; N A Jenkins; L F Parada; N G Copeland Journal: Genes Dev Date: 1994-05-01 Impact factor: 11.361
Authors: Joseph D Dougherty; Susan E Maloney; David F Wozniak; Michael A Rieger; Lisa Sonnenblick; Giovanni Coppola; Nathaniel G Mahieu; Juliet Zhang; Jinlu Cai; Gary J Patti; Brett S Abrahams; Daniel H Geschwind; Nathaniel Heintz Journal: J Neurosci Date: 2013-02-13 Impact factor: 6.167
Authors: Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta Journal: Behav Genet Date: 2020-02-05 Impact factor: 2.805
Authors: Jiayang Chen; Mary E Lambo; Xia Ge; Joshua T Dearborn; Yating Liu; Katherine B McCullough; Raylynn G Swift; Dora R Tabachnick; Lucy Tian; Kevin Noguchi; Joel R Garbow; John N Constantino; Harrison W Gabel; Keith B Hengen; Susan E Maloney; Joseph D Dougherty Journal: Neuron Date: 2021-10-05 Impact factor: 17.173
Authors: Susan E Maloney; Catherine E Creeley; Richard E Hartman; Carla M Yuede; Charles F Zorumski; Vesna Jevtovic-Todorovic; Krikor Dikranian; Kevin K Noguchi; Nuri B Farber; David F Wozniak Journal: Neurobiol Learn Mem Date: 2018-03-14 Impact factor: 2.877
Authors: Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty Journal: eNeuro Date: 2018-07-09
Authors: Laurie P Sutton; Brian S Muntean; Olga Ostrovskaya; Stefano Zucca; Maria Dao; Cesare Orlandi; Chenghui Song; Keqiang Xie; Kirill A Martemyanov Journal: PLoS Biol Date: 2019-10-10 Impact factor: 8.029
Authors: Joseph D Dougherty; Susan E Maloney; Rachel M Rahn; Claire T Weichselbaum; David H Gutmann Journal: J Neurodev Disord Date: 2021-03-20 Impact factor: 4.074
Authors: Elena Minakova; Simona Sarafinovska; Marwa O Mikati; Kia M Barclay; Katherine B McCullough; Joseph D Dougherty; Ream Al-Hasani; Susan E Maloney Journal: Front Behav Neurosci Date: 2021-02-22 Impact factor: 3.617